Press Releases

Results found (114)
May 24, 2016
Yissum to Receive $1.2 million of Funding from Aurum Ventures for...

Non-invasive diagnostic test realizes the potential of circulating DNA for detection of multiple diseases

May 4, 2016
Yissum and BioTheryX Sign Licensing Agreement for the Development of...

The novel technology was developed by Yinon Ben-Neriah, MD, PhD, Blumenthal Professor of Cancer Research, Lautenberg Center for Immunology, Hebrew University-Hadassah Medical School, with generous support by AMRF (The Dr. Miriam...

March 31, 2016
Yissum Showcases Hebrew University’s Breakthroughs in Advanced Materials...

Conference focusing on innovations in nanotechnology, sensors, coating materials, electronic and 3D printing, to take place on March 29 at Hebrew University Edmond J. Safra campus.
During 2015, Yissum founded a record number of eight companies...

March 14, 2016
Yissum Forms Neteera Technologies for Remote Sensing of Biological Indicators

Neteera Technologies Raises 2 Million US Dollars.  
Novel technology, based on electromagnetic properties of human sweat ducts, enables biometric identification along with monitoring of stress, fatigue, pain, alcohol influence, drug abuse...

March 7, 2016
Melodea Wins Nanotechnology Innovation of the Year Award at NanoIsrael 2016

Melodea develops environmentally-friendly, nano-crystalline cellulose based products from side streams of the paper industry

February 25, 2016
Avraham Pharmaceuticals Closes an Additional Investment Round of...

Capital to be used for completion of on-going Phase 2b study of ladostigil, for treatment of mild cognitive impairment, and preparations for pivotal Phase 3 trial

October 26, 2015
Yissum Announces Formation of Agritech Investment Fund

The first projects to be funded by Agrinnovation include protective coating for extension of shelf-life of fruits and vegetables, controlled release of drugs for farm animals, and invention for protection of plants via electronic means.

July 28, 2015
Avraham Pharmaceuticals Announces Successful Second Interim Results in Phase...

Results show positive trends in primary end point of delaying or preventing onset of Alzheimer’s diseaseFinal results expected in Q3 2016, following 3 years of treatment

July 27, 2015
Yissum Introduces a Novel Technology for Drug Screening and Testing of...

The novel technology by Prof. Nissim Benvenisty utilizes stem cells as models for genetic disorders and enables large scale screening of small molecule drugs

July 2, 2015
Merck KGaA acquires Qlight Nanotech

Qlight Nanotech’s staff will remain at the Company’s site at the Hebrew University of Jerusalem, and will function as the research base for Merck for quantum-materials for the display and lighting industry

June 18, 2015
Yissum and ICL Expand Research Collaboration in the Area of Advanced Materials

Yissum Research Development Company Ltd., the Technology Transfer Company of the Hebrew University of Jerusalem, announced today that it had signed multiple research and licensing agreements in the area of advanced materials with ICL (NYSE and...

May 25, 2015
A New Drug on Market! Santen announces Approval of Ikervis for EU Marketing...

Santen Pharmaceutical Co., Ltd. today announced it received approval of the Marketing Authorization Application (MAA) for Ikervis from the European Commission. Ikervis is approved for treatment of severe keratitis in adult patients with dry eye...